Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHargreaves Serv Regulatory News (HSP)

Share Price Information for Hargreaves Serv (HSP)

Share Price is delayed by 15 minutes
Get Live Data
794.00    2.00 (0.25%)
Bid:
782.00
Ask:
808.00
Spread: 26.00 (3.325%)
Market Cap: £243.79m
HSP Live PriceLast checked at - London Stock Exchange

Intraday Hargreaves Serv Share Chart

Contract Award

24 Mar 2021 07:00

RNS Number : 2434T
Hargreaves Services PLC
24 March 2021
 

 24 March 2021

 

Hargreaves Services plc

("Hargreaves" or the "Group")

 

Contract Award

Hargreaves Services plc (AIM: HSP), a diversified group delivering services to the industrial and property sectors, is pleased to announce that its specialist earthworks business, Blackwell, has been appointed by the EKFB JV to carry out earthworks on part of the HS2 project.

The appointment follows Blackwell's 2018 engagement by the EKFB team as an advance works contractor and falls on the ninth anniversary of Blackwell's association with the HS2 programme in a professional services capacity.

The subcontract appointment is for 30km of the HS2 earthworks centred on Aylesbury in Buckinghamshire and involves the movement of nearly 15 million cubic meters of chalk and clay over the next four years. The award is the largest in Blackwell's 65 year history.

The award is a welcome addition to the Group's steadily growing order book, adding to the six framework agreements previously announced in the first half of the financial year. The appointment demonstrates further progress in the Group's stated plan to deliver reliable and growing profits from Distribution & Services.

Commenting on the appointment, Roger McDowell, the Chairman of Hargreaves, said: 'This is an excellent new award for our specialist earthworks business. HS2 is a significant high profile infrastructure project and the Board is pleased that this underpins the Blackwell business over the next few years.'

Note: EKFB JV is a joint venture comprising Eiffage, Kier, Ferrovial Construction and BAM Nuttall which has been appointed by HS2 Limited to complete the C2/C3 section of the HS2 Phase 1 project. Further details can be found at www.EKFB.com.

 

For further details: 

Hargreaves Services

Gordon Banham, Chief Executive Officer

John Samuel, Group Finance Director

 

0191 373 4485

Buchanan (Financial PR)

Mark Court/Sophie Wills/Henry Wilson

 

0207 466 5000

N+1 Singer (Nomad and Joint Corporate Broker)

Sandy Fraser/Justin McKeegan/Rachel Hayes

 

0207 496 3000

Investec (Joint Corporate Broker)

Sara Hale/David Anderson/Shalin Bhamra

0207 597 5970

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTFLFIDVDIVFIL
Date   Source Headline
29th Aug 20247:00 amRNSTransfer of shares held in Treasury
27th Aug 20241:14 pmRNSPDMR Dealing
23rd Aug 20245:28 pmRNSHolding(s) in Company
23rd Aug 202412:29 pmRNSDirector/PDMR Dealing
22nd Aug 20247:00 amRNSTransfer of shares held in Treasury
21st Aug 20241:19 pmRNSDirector/PDMR Shareholding
15th Aug 20243:49 pmRNSExercise of Options and Total Voting Rights
9th Aug 20247:00 amRNSExercise of Options and Total Voting Rights
6th Aug 20243:18 pmRNSHolding(s) in Company
6th Aug 20247:00 amRNSPreliminary results
31st Jul 202412:00 pmRNSConfirmation of preliminary results
24th Jul 202412:00 pmRNSChange of date of preliminary results
3rd Jul 20247:00 amRNSAppointment of Joint Broker
25th Jun 20247:00 amRNSConfirmation of prelim results
6th Jun 20247:00 amRNSTrading Update and Notice of Preliminary Results
28th Mar 20243:21 pmRNSPDMR/PCA Share Transfer
20th Mar 20244:29 pmRNSTransfer of shares held in Treasury
15th Mar 20244:00 pmRNSPDMR/PCA Share Transfer
5th Mar 202410:06 amRNSDirector/PDMR Dealing
4th Mar 20247:00 amRNSRetirement Benefit Obligation Buy In update
5th Feb 202410:31 amRNSHolding(s) in Company
31st Jan 202412:14 pmRNSDirector / PDMR Dealing
24th Jan 20247:00 amRNSInterim results
10th Jan 20247:00 amRNSConfirmation of interim results
21st Dec 202311:58 amRNSPDMR Dealing
21st Dec 20237:00 amRNSTrading Update, Notice of Results, Dividend Payout
7th Nov 202311:34 amRNSShare Options Awards
30th Oct 202311:56 amRNSDirector/PDMR Dealing
25th Oct 20232:45 pmRNSResult of AGM
25th Oct 20237:00 amRNSAGM Statement
23rd Oct 202312:27 pmRNSPDMR and PCA Share Sale/Purchase
17th Oct 202310:40 amRNSDirector/PDMR Dealing
6th Oct 20233:08 pmRNSExercise of Options and Total Voting Rights
22nd Sep 20239:36 amRNSNotice of AGM & Posting of Annual Report &Accounts
5th Sep 20232:49 pmRNSTransfer of shares held in Treasury
31st Aug 20237:00 amRNSBoard responsibilities
30th Aug 202310:32 amRNSTransfer of shares held in Treasury/ PDMR Dealing
15th Aug 202311:15 amRNSDirector/PDMR Shareholding
3rd Aug 202310:15 amRNSConfirmation of prelims and investor presentation
1st Aug 20237:00 amRNSBoard changes
25th Jul 20237:00 amRNSValuation and Realisation Plan for Renewables
24th Jul 202312:48 pmRNSChange to date of Preliminary Results
23rd Jun 20231:35 pmRNSConfirmation of prelims and investor presentation
21st Jun 20231:10 pmRNSHolding(s) in Company
12th Jun 20231:28 pmRNSExercise of Options
8th Jun 20237:00 amRNSTrading update and notice of preliminary results
5th Jun 20237:00 amRNSBoard Responsibilities
1st Jun 20231:44 pmRNSDirector/PDMR Dealing
20th Apr 20235:15 pmRNSHolding(s) in Company
17th Apr 20239:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.